Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 225 (RN7SKP225) is a genomic sequence classified as a pseudogene of the 7SK small nuclear RNA[6]. Pseudogenes are DNA sequences similar to known genes but generally do not encode functional RNA or protein products and are considered non-functional remnants of gene duplication or retrotransposition events[6]. RN7SKP225 does not appear to encode a functional RNA transcript, has no reported biological function, and is not considered a therapeutic target such as a receptor, enzyme, transporter, or transcription factor[6]. There are no associated diseases, biomarker roles, therapeutic drugs, or mechanisms of action reported, and it is not referenced for any safety or efficacy concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 225 (RN7SKP225).